- Sufentanil
- R-30730
- Sufentanyl
Ziporyn, T. A growing industry and menace: Makeshift laboratory’s designer drugs JAMA, 12 Dec 1986, 256 (22), 3061–3063. 486 kB. https://doi.org/10.1001/jama.1986.03380220011003
Burns, SM; Cunningham, CW; Mercer, SL. DARK classics in chemical neuroscience: Fentanyl ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2428-2437. 1.4 MB. https://doi.org/10.1021/acschemneuro.8b00174 #Sufentanil
Ellis, CR; Kruhlak, NL; Kim, MT; Hawkins, EG; Stavitskaya, L. Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking PLOS ONE, 24 May 2018, 13 (5), e0197734. 5.5 MB. https://doi.org/10.1371/journal.pone.0197734 #Sufentanil
Wilde, M; Pichini, S; Pacifici, R; Tagliabracci, A; Busardò, FP; Auwärter, V; Solimini, R. Metabolic pathways and potencies of new fentanyl analogs Front. Pharmacol., 5 Apr 2019, 10 (238). 1.5 MB. https://doi.org/10.3389/fphar.2019.00238 #Sufentanil
Armenian, P; Vo, KT; Barr-Walker, J; Lynch, KL. Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review Neuropharmacology, 1 May 2018, 134, 121–132. 847 kB. https://doi.org/10.1016/j.neuropharm.2017.10.016 #Sufentanil
Ringuette, AE; Spock, M; Lindsley, CW; Bender, AM. DARK classics in chemical neuroscience: Carfentanil ACS Chem. Neurosci., 2 Dec 2020, 11 (23), 3955–3967. 3.6 MB. https://doi.org/10.1021/acschemneuro.0c00441 #4